Rezolute, Inc. (RZLT)
9.85
-0.32
(-3.15%)
USD |
NASDAQ |
Dec 09, 16:00
9.97
+0.12
(+1.22%)
Pre-Market: 08:22
Rezolute EPS Diluted (Quarterly): -0.1755 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Astria Therapeutics, Inc. | -0.5455 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.15M |
| Total Expenses (Quarterly) | 18.15M |
| Enterprise Value | 762.63M |
| Earnings Yield | -9.43% |
| Normalized Earnings Yield | -9.432 |